- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07528599
Virtual Reality-based Motor Imagery in Patients With Fibromyalgia
April 7, 2026 updated by: BÜŞRA CANDİRİ, Inonu University
The Effect of Virtual Reality-Based Motor Imagery on Pain, Psychological Status and Quality of Life in Fibromyalgia Patients
This study investigated the effects of a virtual reality-based motor imagery intervention integrated into a conventional exercise programme on pain outcomes (pain intensity, central sensitisation, pressure pain threshold, galvanic skin response, pain catastrophising), quality of life, sleep quality, fatigue, psychological outcomes (Hospital Anxiety and Depression Scale), imagery ability and patient satisfaction.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The study will include individuals aged 18-60 who have been diagnosed with fibromyalgia.
Participants will be randomly assigned to one of two groups using a sealed-envelope method: the traditional exercise + virtual reality-assisted motor imagery group, or the traditional exercise + non-virtual reality motor imagery group.
In both groups, participants will undergo a traditional rehabilitation programme three days a week under the supervision of a physiotherapist.
In the experimental group, three virtual reality games targeting the upper extremities, trunk and lower extremities will be shown for three minutes each, followed by two minutes of motor imagery.
In the control group, the same protocol will be carried out via a monitor without virtual reality.
All assessments will be conducted before treatment and at the end of 6 weeks.
Pain intensity, Visual Analogue Scale; central sensitivity, Central Sensitivity Inventory; pain catastrophising, Pain Catastrophising Scale; general quality of life, Fibromyalgia Impact Questionnaire; pressure pain threshold, algometer; sleep quality, Pittsburgh Sleep Quality Index; fatigue severity, Fatigue Severity Scale; psychological state, Hospital Anxiety and Depression Scale; patient satisfaction, Patient's General Impression of Change Scale; and imagery ability, Kinesthetic and Visual Imagery Questionnaire-10.
Study Type
Interventional
Enrollment (Estimated)
28
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Büşra CANDİRİ
- Phone Number: +905073780717
- Email: candiri_17@hotmail.com
Study Contact Backup
- Name: İrem YİĞİT
- Phone Number: +905375427930
- Email: iremmyigitt@outlook.com
Study Locations
-
-
-
Malatya, Turkey (Türkiye)
- Inonu University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- To be a volunteer,
- To have been diagnosed with fibromyalgia according to the 2016 ACR diagnostic criteria,
- To be aged between 18 and 60,
- To have had pain symptoms for at least 3 months,
- To be receiving standard medical treatment,
Exclusion Criteria:
- The presence of neurological or orthopaedic conditions that would prevent participation in the rehabilitation programme
- Pregnancy,
- The presence of cognitive impairments that could affect cooperation,
- The presence of serious, uncontrolled health problems,
- A history of lower limb or spinal surgery
- Visual or hearing impairments;
- Serious psychiatric disorders
- A diagnosis of migraine
- Regular physical exercise in the last three months (≥2 days per week)
- Participation in any concurrent physiotherapy or rehabilitation intervention
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: conventional exercise + motor imagery without virtual reality
Participants will undergo a traditional rehabilitation programme three days a week under the supervision of a physiotherapist.
Three virtual reality games targeting the upper limbs, trunk and lower limbs will be used; participants will watch these games on a monitor and visualise the movements.
|
Participants in the control groups will undergo a structured conventional exercise programme under the supervision of a physiotherapist, three days a week for six weeks.
The conventional exercise programme has been designed to include stretching, postural control and muscle strengthening components.
Each session will last approximately 30 minutes.
The intensity and difficulty level of the exercises will be gradually increased every two weeks and progressed in a controlled manner.
In the control group, recorded versions of virtual reality games will be presented via a standard monitor screen without the use of a virtual reality headset.
Participants will watch each video for three minutes and will then be asked to visualise the same movements for two minutes.
The total duration of the motor imagery intervention in the control group will also be 15 minutes.
Other Names:
|
|
Experimental: conventional exercise + motor imagery with virtual reality
Participants will undergo a traditional rehabilitation programme three days a week under the supervision of a physiotherapist.
Participants will watch three virtual reality games, each lasting three minutes and targeting the upper limbs, trunk and lower limbs, and will then perform motor imagery for two minutes.
|
A structured conventional exercise programme will be implemented three days a week for six weeks.
The conventional exercise programme has been designed to include components of stretching, postural control and muscle strengthening.
Each session will last approximately 30 minutes.
The intensity and difficulty level of the exercises will be gradually increased every two weeks and progressed in a controlled manner.
In the experimental group, motor imagery exercises will be performed by creating a virtual environment using the provided virtual reality headset.
In this group, a total of three different virtual reality games targeting the upper limbs, trunk and lower limbs will be used.
Each game will be viewed for three minutes via the virtual reality headset, after which participants will be asked to mentally visualise the relevant movements for two minutes.
The total duration of the motor imagery intervention is planned to be 15 minutes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain assessment
Time Frame: baseline
|
Pain during rest and activity will be assessed using the VAS.
The VAS is a 10-cm scale where 0 points indicate 'no pain' and 10 points indicate 'the worst pain imaginable'.
Participants will be asked to mark the scale based on their assessment of pain intensity over the past 24 hours.
Pain intensity will be measured using the scale and recorded in centimetres.
|
baseline
|
|
pain assessment
Time Frame: 6 weeks
|
Pain during rest and activity will be assessed using the VAS.
The VAS is a 10-cm scale where 0 points indicate 'no pain' and 10 points indicate 'the worst pain imaginable'.
Participants will be asked to mark the scale based on their assessment of pain intensity over the past 24 hours.
Pain intensity will be measured using the scale and recorded in centimetres.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure Pain Threshold Assessment
Time Frame: Baseline
|
An algometer will be used to assess the pressure pain threshold.
During the assessment, tender points at the occipital base, lower cervical region, trapezius, supraspinatus, second costochondral joint, lateral epicondyle and medial knee border will be measured bilaterally.
In addition, the patient will be asked to stand upright so that the tender points of the gluteus and greater trochanter can also be assessed.
Each measurement will be repeated three times bilaterally, and the average of the values obtained will be recorded.
|
Baseline
|
|
Pressure pain threshold assessment
Time Frame: 6 weeks
|
An algometer will be used to assess the pressure pain threshold.
During the assessment, tender points at the occipital base, lower cervical region, trapezius, supraspinatus, second costochondral joint, lateral epicondyle and medial knee border will be measured bilaterally.
In addition, the patient will be asked to stand upright so that the tender points of the gluteus and greater trochanter can also be assessed.
Each measurement will be repeated three times bilaterally, and the average of the values obtained will be recorded.
|
6 weeks
|
|
Galvanic Skin Response
Time Frame: Baseline
|
Galvanic skin response is an important physiological parameter that measures changes in the electrical conductivity of the skin surface and reflects sympathetic nervous system activity.
It is frequently used as a non-invasive, reliable and sensitive method for assessing autonomic nervous system responses.
In this study, galvanic skin response measurements will be carried out using a galvanic skin response sensor to be acquired as part of the project, with the aim of objectively evaluating the effects of a virtual reality-based motor imagery intervention on autonomic physiological responses.
The galvanic skin response will be recorded.
|
Baseline
|
|
Galvanic Skin Response
Time Frame: 6 weeks
|
Galvanic skin response is an important physiological parameter that measures changes in the electrical conductivity of the skin surface and reflects sympathetic nervous system activity.
It is frequently used as a non-invasive, reliable and sensitive method for assessing autonomic nervous system responses.
In this study, galvanic skin response measurements will be carried out using a galvanic skin response sensor to be acquired as part of the project, with the aim of objectively evaluating the effects of a virtual reality-based motor imagery intervention on autonomic physiological responses.
The galvanic skin response will be recorded .
|
6 weeks
|
|
Central Sensitivity Inventory
Time Frame: Baseline
|
The Central Sensitivity Inventory is a patient-completed questionnaire used to assess the severity of central sensitivity symptoms associated with chronic pain.
The questionnaire consists of 9 items, each of which examines pain and associated symptoms originating from the central nervous system.
High scores on the scale indicate that symptoms of central sensitisation are more pronounced and severe; low scores, on the other hand, indicate a milder level of central sensitisation.
|
Baseline
|
|
Central Sensitivity Inventory
Time Frame: 6 weeks
|
The Central Sensitivity Inventory is a patient-completed questionnaire used to assess the severity of central sensitivity symptoms associated with chronic pain.
The questionnaire consists of 9 items, each of which examines pain and associated symptoms originating from the central nervous system.
High scores on the scale indicate that symptoms of central sensitisation are more pronounced and severe; low scores, on the other hand, indicate a milder level of central sensitisation.
|
6 weeks
|
|
Pain Catastrophising Scale
Time Frame: Baseline
|
A 13-item self-report instrument that assesses individuals' catastrophising regarding pain, i.e. their negative cognitive and emotional responses.
The scale covers the dimensions of pain exaggeration, feelings of helplessness and persistent negative thoughts.
A high score is associated with an intensified perception of pain in patients with chronic pain .
|
Baseline
|
|
Pain Catastrophising Scale
Time Frame: 6 weeks
|
A 13-item self-report instrument that assesses individuals' catastrophising regarding pain, i.e. their negative cognitive and emotional responses.
The scale covers the dimensions of pain exaggeration, feelings of helplessness and persistent negative thoughts.
A high score is associated with an intensified perception of pain in patients with chronic pain
|
6 weeks
|
|
Revised Fibromyalgia Impact Questionnaire
Time Frame: Baseline
|
The Revised Fibromyalgia Impact Questionnaire is used to assess the overall impact of fibromyalgia on a patient's daily life, functional status and symptom burden.
It is a reliable and valid tool for monitoring disease severity and response to treatment in both clinical practice and research.
The scale consists of three sub-sections: functional status, overall impact and symptoms, and contains a total of 21 items.
Items are scored on a scale of 0-10, and the sub-sections are adjusted using specific weightings to produce an overall score out of 100.
A higher score is associated with a more severe clinical presentation and a lower quality of life.
|
Baseline
|
|
Revised Fibromyalgia Impact Questionnaire
Time Frame: 6 weeks
|
The Revised Fibromyalgia Impact Questionnaire is used to assess the overall impact of fibromyalgia on a patient's daily life, functional status and symptom burden.
It is a reliable and valid tool for monitoring disease severity and response to treatment in both clinical practice and research.
The scale consists of three sub-sections: functional status, overall impact and symptoms, and contains a total of 21 items.
Items are scored on a scale of 0-10, and the sub-sections are adjusted using specific weightings to produce an overall score out of 100.
A higher score is associated with a more severe clinical presentation and a lower quality of life.
|
6 weeks
|
|
Hospital Anxiety and Depression Scale
Time Frame: Baseline
|
The Hospital Anxiety and Depression Scale is used to measure patients' levels of anxiety and depression.
It is a self-report scale comprising a total of 14 items.
Seven items assess anxiety levels, whilst the other seven assess depression levels.
Each item is scored on a scale of 0 to 3 using a 4-point Likert-type scale.
The cut-off value is set at 10 for anxiety and 7 for depression.
|
Baseline
|
|
Hospital Anxiety and Depression Scale
Time Frame: 6 weeks
|
The Hospital Anxiety and Depression Scale is used to measure patients' levels of anxiety and depression.
It is a self-report scale comprising a total of 14 items.
Seven items assess anxiety levels, whilst the other seven assess depression levels.
Each item is scored on a scale of 0 to 3 using a 4-point Likert-type scale.
The cut-off value is set at 10 for anxiety and 7 for depression.
|
6 weeks
|
|
Pittsburgh Sleep Quality Index
Time Frame: Baseline
|
The Pittsburgh Sleep Quality Index will be used to assess sleep quality over the past month.
It consists of a total of 24 questions, 18 of which are answered by the individual, and the assessment is based on seven components: subjective sleep quality, time taken to fall asleep, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime functional impairment.
Each item is scored on a scale of 0-3, and the sum of the component scores forms the overall sleep quality score.
The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.
|
Baseline
|
|
Pittsburgh Sleep Quality Index
Time Frame: 6 weeks
|
The Pittsburgh Sleep Quality Index will be used to assess sleep quality over the past month.
It consists of a total of 24 questions, 18 of which are answered by the individual, and the assessment is based on seven components: subjective sleep quality, time taken to fall asleep, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime functional impairment.
Each item is scored on a scale of 0-3, and the sum of the component scores forms the overall sleep quality score.
The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.
|
6 weeks
|
|
Fatigue Severity Scale
Time Frame: Baseline
|
The Fatigue Severity Scale assesses individuals' levels of fatigue over the past month.
It is a 9-item self-report instrument.
Each item is scored on a scale of 1 to 7, with higher scores indicating greater fatigue severity .
|
Baseline
|
|
Fatigue Severity Scale
Time Frame: 6 weeks
|
The Fatigue Severity Scale assesses individuals' levels of fatigue over the past month.
It is a 9-item self-report instrument.
Each item is scored on a scale of 1 to 7, with higher scores indicating greater fatigue severity.
|
6 weeks
|
|
Patient's General Perception of Change Scale
Time Frame: Baseline
|
Following completion of the exercise programme, patients will be asked to assess changes in their symptoms before and after treatment.
The 7-point Likert-scale PGPCS will be used to subjectively measure patients' response to treatment.
The scale allows patients to rate changes in their general health status as follows: 1) improved considerably, 2) improved a lot, 3) improved slightly, 4) no change, 5) slightly worse, 6) worse, 7) much worse.
It is widely used in clinical trials and routine practice to assess patients' response to treatment quickly and effectively.
|
Baseline
|
|
Patient's General Perception of Change Scale
Time Frame: 6 weeks
|
Following completion of the exercise programme, patients will be asked to assess changes in their symptoms before and after treatment.
The 7-point Likert-scale PGPCS will be used to subjectively measure patients' response to treatment.
The scale allows patients to rate changes in their general health status as follows: 1) improved considerably, 2) improved a lot, 3) improved slightly, 4) no change, 5) slightly worse, 6) worse, 7) much worse.
It is widely used in clinical trials and routine practice to assess patients' response to treatment quickly and effectively.
|
6 weeks
|
|
Kinesthetic and Visual Imagery Questionnaire
Time Frame: Baseline
|
The Kinesthetic and Visual Imagery Questionnaire aims to determine the extent to which individuals can visualise and kinesthetically perceive the movements they imagine.
All items are administered whilst the participant is seated and consist of two subscales: visual imagery and kinesthetic imagery.
In the Kinesthetic and Visual Imagery Questionnaire, each item is scored on a scale of 1-5 (1 = no sensation/image, 5 = as intense as if performing the movement/as clear as the real thing), with the total score ranging from 10 to 50; higher scores indicate better imagery ability.
|
Baseline
|
|
Kinesthetic and Visual Imagery Questionnaire
Time Frame: 6 weeks
|
The Kinesthetic and Visual Imagery Questionnaire aims to determine the extent to which individuals can visualise and kinesthetically perceive the movements they imagine.
All items are administered whilst the participant is seated and consist of two subscales: visual imagery and kinesthetic imagery.
In the Kinesthetic and Visual Imagery Questionnaire, each item is scored on a scale of 1-5 (1 = no sensation/image, 5 = as intense as if performing the movement/as clear as the real thing), with the total score ranging from 10 to 50; higher scores indicate better imagery ability.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 25, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
April 7, 2026
First Submitted That Met QC Criteria
April 7, 2026
First Posted (Actual)
April 14, 2026
Study Record Updates
Last Update Posted (Actual)
April 14, 2026
Last Update Submitted That Met QC Criteria
April 7, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026/9676
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia Patients
-
hatice kübra aşıkBezmialem Vakif University; University of BeykentEnrolling by invitationFibromyalgia Syndrome | Patients with Clinical Complaints of Fibromyalgia Among the Patients Applying to the Outpatient ClinicTurkey
-
Assiut UniversityNot yet recruitingPsychological Symptoms in Fibromyalgia Patients
-
Ondokuz Mayıs UniversityActive, not recruitingPatients Diagnosed With Fibromyalgia SyndromeTurkey (Türkiye)
-
Institut Nacional d'Educacio Fisica de CatalunyaCompletedFibromyalgia | Hormonal Responses to Exercise in Patients With Fibromyalgia.Spain
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
Clinical Trials on conventional exercise + motor imagery without virtual reality
-
Istanbul University - Cerrahpasa (IUC)Not yet recruiting
-
Riphah International UniversityCompleted
-
Abant Izzet Baysal UniversityRecruiting
-
Green International UniversityCompletedComplex Regional Pain Syndrome (CRPS) | Shoulder Hand SyndromePakistan
-
Xiaodong ChengCompletedExecutive Function (Cognition) | Shooting PerformanceChina
-
Ege UniversityThe Scientific and Technological Research Council of TurkeyCompletedMotor Imagery Training | Virtual Reality | Resistance TrainingTurkey (Türkiye)
-
Riphah International UniversityCompleted
-
Riphah International UniversityRecruitingPain | Cervical Pain | KinesiophobiaPakistan
-
dongmin kangEnrolling by invitationCentral Sensitization | Virtual Reality | Kinesiophobia | Chronic Low Back Pain (CLBP) | Fear of MovementSouth Korea
-
Hacettepe UniversityNot yet recruitingSpecific Learning Disability